Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 190, 113368
Abstract
No abstract availableKeywords
Funding Information
- Andy Hill CARE Fund
- National Institutes of Health (U01 CA217655)
- National Cancer Institute (R03 CA227352, U54 CA199090)
This publication has 44 references indexed in Scilit:
- From Krebs to clinic: glutamine metabolism to cancer therapyNature Reviews Cancer, 2016
- Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-HydroxyglutarateACS Chemical Biology, 2014
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- Cellular Heterogeneity and Molecular Evolution in CancerAnnual Review of Pathology: Mechanisms of Disease, 2013
- Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarateActa Neuropathologica, 2012
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?Cell, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- mTOR signaling in glioblastoma: lessons learned from bench to bedsideNeuro-Oncology, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease statesCarcinogenesis, 2007